Correo

U.S. markets open in 19 minutes

F S&P 500
5,125.50
-21.50(-0.42%)
F Dow Jones
38,388.00
-171.00(-0.44%)
F Nasdaq
17,821.00
-83.25(-0.46%)
E-mini Russell 2000 Index Futur
2,006.30
-20.80(-1.03%)
Petróleo
82.84
+0.21(+0.25%)
Oro
2,318.40
-39.30(-1.67%)

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Precio retrasado. Divisa en USD.

Añadir a la lista de seguimiento

0.0100

0.0000

(0.00%)

Al cierre: 10:26AM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Nómina de miembros de la gerencia

Persona o entidad	Transacción más reciente	Fecha	Acciones adquiridas a partir de la fecha de transacción
ABUSE DETERRENT PHARMA, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	08 jun 2021	42,984,400
BRZECZKO ALBERT W Officer	Conversion of Exercise of derivative security	19 nov 2023	486,001
CLEMENS PETER A Chief Financial Officer	Conversion of Exercise of derivative security	19 nov 2023	545,430
JONES ROBERT B. Chief Executive Officer	Conversion of Exercise of derivative security	19 nov 2023	643,555
ROSS GEORGE K Director	Conversion of Exercise of derivative security	01 ene 2024	495,503
SEISER ROBERT A Officer and Treasurer	Conversion of Exercise of derivative security	19 nov 2023	438,254
SKELLY WILLIAM G Director	Conversion of Exercise of derivative security	01 ene 2024	575,989
THANGARAJ IMMANUEL Director	Conversion of Exercise of derivative security	01 ene 2024	2,404,040
WESSON BRUCE F Divisional Officer	Conversion of Exercise of derivative security	01 ene 2024	829,548
*La lista miembros de la gerencia se deriva únicamente de los últimos 24 meses de las presentaciones SEC de las Planillas 3 y 4.